PT Jayamas Medica Industri Tbk (OMED.JK)
IDR 184.0
(-2.14%)
IDR 184.0
(-2.14%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 371.38 Billion IDR | -10.67% |
| 2022 | 415.7 Billion IDR | -45.89% |
| 2021 | 768.19 Billion IDR | -11.86% |
| 2020 | 872.21 Billion IDR | 26039.46% |
| 2019 | 305.78 Billion IDR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 91.3 Billion IDR | -20.51% |
| 2024 Q2 | 109.34 Billion IDR | 19.75% |
| 2023 Q2 | 80.93 Billion IDR | 3.1% |
| 2023 Q4 | 115.12 Billion IDR | 19.02% |
| 2023 Q1 | 78.5 Billion IDR | -36.31% |
| 2023 FY | - IDR | -10.67% |
| 2023 Q3 | 96.71 Billion IDR | 19.5% |
| 2022 Q3 | 96.1 Billion IDR | 0.0% |
| 2022 FY | - IDR | -45.89% |
| 2022 Q4 | 123.26 Billion IDR | 28.25% |
| 2021 FY | - IDR | -11.86% |
| 2020 FY | - IDR | 26039.46% |
| 2019 FY | - IDR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| PT Mark Dynamics Indonesia Tbk | 234.35 Billion IDR | -58.469% |
| PT Hetzer Medical Indonesia Tbk | 1.22 Billion IDR | -30146.949% |
| Maja Agung Latexindo Tbk. | 978.07 Million IDR | -37870.986% |